The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats

In support of accelerated development of Ebola vaccines from preclinical research to clinical trials, in November, 2014, the Wellcome Trust and the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota established the Wellcome Trust-CIDRAP Ebola Vaccine Team B ini...

Descripción completa

Detalles Bibliográficos
Autores principales: Osterholm, Michael, Moore, Kristine, Ostrowsky, Julie, Kimball-Baker, Kathleen, Farrar, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106346/
https://www.ncbi.nlm.nih.gov/pubmed/26526664
http://dx.doi.org/10.1016/S1473-3099(15)00416-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106346/
https://www.ncbi.nlm.nih.gov/pubmed/26526664
http://dx.doi.org/10.1016/S1473-3099(15)00416-8

Ejemplares similares